Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Price to Cash Earnings (PCE)

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) -14.55-32.04-27.62

What is the latest Price to Cash Earnings (PCE) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Price to Cash Earnings (PCE) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -14.55 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2025-14.55
Mar2024-32.04
Mar2023-27.62

How is Price to Cash Earnings (PCE) of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 -14.55
Negative
Mar2024 -32.04
Negative
Mar2023 -27.62 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Price to Cash Earnings (PCE) ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹4,807.5 Cr 20.6% 22.6% -2.6% Stock Analytics
SAGILITY INDIA ₹19,708.4 Cr -0.8% 7.9% 1.5% Stock Analytics
SYNGENE INTERNATIONAL ₹16,309.0 Cr 1.3% 1.5% -47.3% Stock Analytics
LATENT VIEW ANALYTICS ₹6,117.7 Cr -1.7% -3% -20.5% Stock Analytics
JUST DIAL ₹4,943.7 Cr 12% 10.2% -32% Stock Analytics
AWFIS SPACE SOLUTIONS ₹2,297.2 Cr 17.8% 26.3% -53.8% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

20.6%

22.6%

-2.6%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses